AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-134165742/warning-trileptal-oxcarbazepine-fda.html" title="Facts and information about Warning on Trileptal (oxcarbazepine).(From the FDA)(Brief Article)">Warning on Trileptal (oxcarbazepine).(From the FDA)(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from The Brown University Geriatric Psychopharmacology Update are available.
Frequently asked questions about RSS feeds
Warning on Trileptal (oxcarbazepine).(From the FDA)(Brief Article)
The FDA and Novartis Pharmaceuticals have notified healthcare professionals about updated Warnings and Precautions sections of labeling for Trileptal (oxcarbazepine) tablets and oral suspension. The drug is used as monotherapy or adjunctive therapy for treating partial seizures in adults and children aged 14 to 16 years with epilepsy. The new warning describes serious dermatalogical reactions, ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Warning on Trileptal (oxcarbazepine).(From the FDA)(Brief Article)
- Magazine article from: Brown University Psychopharmacology Update August 1, 2005 700+ words
...Precautions sections of labeling for Trileptal (oxcarbazepine) tablets and oral suspension...adults and children in association with Trileptal use. The Precautions section includes...hypersensitivity reactions associated with Trileptal. [www.fda.gov/medwatch]
- Epilepsy Rx.(Trileptal (oxcarbazepine) offered by Novartis Pharmaceuticals...
- Magazine article from: Family Practice News May 1, 2000 700+ words
Trileptal (oxcarbazepine) is indicated as adjunctive therapy or monotherapy for...first antiepilepsy drug to be approved for first-line use in 5 years, Trileptal has better tolerability than older first-line medications and the most...
- Trileptal cleared.(by FDA for Novartis Pharmaceuticals Corp.)(Brief Article)
- Magazine article from: Chain Drug Review July 30, 2001 700+ words
The FDA has granted clearance for an oral suspension of Trileptal, an epilepsy treatment. Novartis Pharmaceuticals Corp. has marketed the drug in tablet form since February.
- Integrated Communications Corp.(gets Trileptal epilepsy drug promotional...
- Magazine article from: Medical Marketing & Media November 1, 2000 700+ words
Integrated Communications Corp. was awarded the promotional responsibility of a new epilepsy drug called Trileptal from Novartis Pharmaceuticals Corp.
- Novartis Pharmaceuticals Corp.(receives marketing clearance for...
- Magazine article from: Medical Marketing & Media March 1, 2000 700+ words
Novartis Pharmaceuticals Corp. was granted marketing clearance by the FDA for the antiepileptic/anticonvulsant Trileptal (oxcarbazepine) tablets, indicated for the treatment of partial seizures as monotherapy in adults or adjunctive therapy in adults and children.
- Trileptal.(Drug overview)
- PDR Family Guide to Prescription Drugs January 22, 2007 700+ words
...LEP-tal Generic name: Oxcarbazepine Why is Trileptal prescribed? Trileptal helps reduce the frequency of partial epileptic...victim remains conscious throughout the attack. Trileptal may be prescribed by itself to treat the problem...
- Trileptal.
- PDR Family Guide to Prescription Drugs December 1, 2005 700+ words
...Oxcarbazepine Why is this drug prescribed? Trileptal helps reduce the frequency of partial...remains conscious throughout the attack. Trileptal may be prescribed by itself to treat...Most important fact about this drug Trileptal can cause drowsiness, dizziness, and...
- Trileptal(R) (oxcarbazepine) is Approved for Use as Monotherapy in Children...
- Press release article from: PR Newswire August 7, 2003 700+ words
...has granted marketing clearance for Trileptal(R) (oxcarbazepine) tablets and oral...seizures four years of age and older. Trileptal is the first antiepileptic drug (AED...improved compliance. "The approval of Trileptal as a pediatric monotherapy is a step...
- Research Suggests Trileptal as Monotherapy May Benefit Patients Suffering From...
- News wire article from: Ascribe Higher Education News Service October 9, 2002 700+ words
...Epileptology, the anti-epileptic drug Trileptal (R) (oxcarbazepine, Novartis Pharmaceuticals...control trials involving 266 patients (149 Trileptal, 117 active control) over an 11-14...that 62 percent of patients receiving Trileptal monotherapy had no generalized tonic...
- Three Studies Support Long-term Use of Trileptal-R- in Patients with Partial...
- Press release article from: Business Wire December 10, 2002 700+ words
...2002 The antiepileptic drug (AED) Trileptal (R) (oxcarbazepine, Novartis Pharmaceuticals...one of the studies. "These data show Trileptal helped reduce seizure frequency over...that examined the safety and efficacy of Trileptal as adjunctive therapy in children (aged...
